{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-021740","form_type":"8-K","ticker":"HCTI","cik":"0001839285","company_name":"Healthcare Triangle, Inc.","filed_at":"2026-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.477851+00:00","generated_at":"2026-05-15T23:10:42.805905+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Healthcare Triangle raises ~$3.96M via registered direct offering of common stock and pre-funded warrants","bullets":["Offering of 421,553 shares and 260,000 pre-funded warrants at $5.81/share; gross proceeds ~$3.959M.","Net proceeds to be used for working capital and general corporate purposes.","D. Boral Capital acted as sole placement agent with 7% cash fee plus expense reimbursement.","Offering closed on February 27, 2026; securities offered under effective shelf registration on Form S-3."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-021740","json":"https://secwatch.observer/filing/0001213900-26-021740.json","markdown":"https://secwatch.observer/filing/0001213900-26-021740.md","text":"https://secwatch.observer/filing/0001213900-26-021740.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026021740/0001213900-26-021740-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026021740/ea0279059-8k_healthcare.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:10:42.805905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ca4a01a7957410d3d756a2a17e8b6bc5270afa1b","claim":"Healthcare Triangle, Inc. entered into Placement Agency Agreement with D. Boral Capital LLC (effective 2026-02-26).","evidence_excerpt":"In connection with the Offering, the Company also entered into a placement agency agreement (the “Placement Agency Agreement”) with D. Boral Capital LLC (the “Placement Agent”), pursuant to which the Company paid the Placement Agent (i) a cash fee equal to 7% of the aggregate gross proceeds of the Offering, and (ii) reimbursed the Placement Agent for certain expenses and legal fees.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026021740/0001213900-26-021740-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"D. Boral Capital LLC"},{"label":"Effective","value":"2026-02-26"}]},{"claim_id":"dc67687e5a9e9ef4919e8d54cb7ba3915c4b8d00","claim":"Healthcare Triangle, Inc. entered into Purchase Agreement with certain institutional investors valued at approximately $3.95 million (effective 2026-02-26).","evidence_excerpt":"On February 26, 2026, Healthcare Triangle, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers in a registered direct offering (A) an aggregate of 421,553 shares (the “Shares”) of common stock, par value $0.00001 per share (the “Common Stock”), of the Company, at an offering price of $5.81 per share, and (B) 260,000 pre-funded warrants (the “Pre-Funded Warrants”) in lieu of shares of Common Stock, at an offering price of $5.80999 (such registered direct offering, the “Offering”) for aggregate gross proceeds of approximately $3.95 million, before deducting Offering expenses payable by the Company, including the Placement Agent’s commissions and fees.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026021740/0001213900-26-021740-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional investors"},{"label":"Value","value":"approximately $3.95 million"},{"label":"Effective","value":"2026-02-26"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}